Malignant biliary tract obstruction: Evaluation and therapy

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 8, Issue 9, 2010, Pages 1033-1044

  Chu, David ^a   Adler, Douglas G ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

Biliary obstruction; ERCP; EUS; Metal biliary stents; Percutaneous transhepatic cholangiogram; Plastic biliary stents

Indexed keywords

POLITEF; POLYETHYLENE;

ABDOMINAL ABSCESS; ASPIRATION BIOPSY; BILE DUCT CARCINOMA; BILE DUCT OBSTRUCTION; BILIARY TRACT DRAINAGE; CANCER MORTALITY; CANCER SURVIVAL; CATHETER; CHOLANGITIS; CHOLECYSTITIS; CLINICAL FEATURE; COST EFFECTIVENESS ANALYSIS; DECOMPRESSION SURGERY; DEHYDRATION; DIAGNOSTIC ACCURACY; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; GASTROJEJUNOSTOMY; HEPATOJEJUNOSTOMY; HUMAN; INTERMETHOD COMPARISON; JAUNDICE; KIDNEY FAILURE; LIVER ABSCESS; LIVER TRANSPLANTATION; LYMPH NODE METASTASIS; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MORBIDITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS FISTULA; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PARTIAL HEPATECTOMY; PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SEPSIS; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SPLENECTOMY; STENT; STOMACH EMPTYING; STOMACH OBSTRUCTION; VATER PAPILLA CARCINOMA; WOUND INFECTION;

EID: 77958163111     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2010.0075     Document Type: Review

References (87)

1. Jemal A, Siegel R, Ward E, et al. Cancer Statistics, 2009. CA Cancer J Clin 2009;59;225-249.
2. Ries LAG, Harkins D, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2003. Bethesda: National Cancer Institute; 2005. Available at: http://seer.cancer.gov/csr/1975-2003/. Accessed June 30, 2010.
3. Lokich JJ, Kane RA, Harrison DA, McDermott WV. Biliary tract obstruction secondary to cancer: management guidelines and selected literature review. J Clin Oncol 1987;5:969-981.
4. van der Gaag NA, Kloek JJ, de Castro SM, et al. Preoperative biliary drainage in patients with obstructive jaundice: history and current status. J Gastrointest Surg 2009;13:814-820.
5. Barkin JS, Goldstein JA. Diagnostic and therapeutic approach to pancreatic cancer. Biomed Pharmacother 2000;54:400-409.
6. Nagorney DM, Donohue JH, Farnell MB, et al. Outcomes after curative resections of cholangiocarcinoma. Arch Surg 1993;128:871-879.
7. Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma a spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996;224:463-473.
8. Goonnetilleke KS, Siriwardena AK. Systematic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol 2007;33:266-270.
9. Steinberg W. The clinical utility of the CA 19-9 tumor associate antigen. Am J Gastroenterol 1990;85:350-355.
10. Mann DV, Edwards R, Ho S, et al. Elevated tumour marker CA19- 9: clinical interpretation and influence of obstructive jaundice. Eur J Surg Oncol 2000;26:474-479.
11. Tse F, Barkun JS, Romagnuolo J, et al. Nonoperative imaging techniques in suspected biliary tract obstruction. HPB (Oxford) 2006;8:409-425.
12. Qiao Q, Zhao Y, Ye M, et al. Carcinoma of the ampulla of Vater: factors influencing long-term survival of 127 patients with resection. World J Surg 2007;31:137-143.
13. Skordilis P, Mouzas IA, Dimoulios PD, et al. Is endosonography an effective method for detection and local staging of the ampullary carcinoma? A prospective study. BMC Surg 2002;2:1.
14. Lindsell DR. Ultrasound imaging of pancreas and biliary tract. Lancet 1990;335:390-393.
15. Ferrari FS, Fantozzi F, Tasciotti L, et al. US, MRCP, CCT and ERCP: a comparative study in 131 patients with suspected biliary obstruction. Med Sci Monit 2005;11:MT8-18.
16. Bipat S, Phoa SS, van Delden OM, et al. Ultrasonography, computed tomography and magnetic resonance imaging for diagnosis and determining resectability of pancreatic adenocarcinoma: a metaanalysis. J Comput Assist Tomogr 2005;29:438-445.
17. Tillich M, Mischinger HJ, Preisegger KH, et al. Multiphasic helical CT in diagnosis and staging of hilar cholangiocarcinoma. AJR Am J Roentgenol 1998;171:651-658. (Pubitemid 28406125)
18. Ott DJ, Gelfand DW. Complications of gastrointestinal radiologic procedures: II. Complications related to biliary tract studies. Gastrointest Radiol 1981;6:47-56.
19. Kwon AH, Uetsuji S, Yamada O, et al. Three-dimensional reconstruction of the biliary tract using spiral computed tomography. Br J Surg 1995;82:260-263.
20. Romagnuolo J, Bardou M, Rahme E, et al. Magnetic resonance cholangiopancreatography: a meta-analysis of test performance in suspected biliary disease. Ann Intern Med 2003;139:547-557.
21. Adamek HE, Albert J, Breer H, et al. Pancreatic cancer detection with magnetic resonance cholangiopancreatography and endoscopic retrograde cholangiopancreatography: a prospective controlled study. Lancet 2000;356:190-193. (Pubitemid 30446973)
22. Soto JA, Alvarez O, Lopera JE, et al. Biliary obstruction: findings at MR cholangiography and cross-sectional MR imaging. Radiographics 2000;20:353-366.
23. Lopez HE, Amthauer H, Hosten N, et al. Prospective evaluation of pancreatic tumors: accuracy of MR imaging with MR cholangiopancreatography and MR angiography. Radiology 2002;224:34-41. (Pubitemid 34680372)
24. Griffin N, Wastle ML, Dunn WK, et al. Magnetic resonance cholangiopancreatography versus endoscopic retrograde cholangiopancreatography in the diagnosis of choledocholithiasis. Eur J Gastroenterol Hepatol 2003;15:809-813. (Pubitemid 36870659)
25. Materne R, van Beers BE, Gigot JF, et al. Extrahepatic biliary obstruction: magnetic resonance imaging compared with endoscopic ultrasonography. Endoscopy 2000;32:3-9. (Pubitemid 30071899)
26. Irisawa A, Sato A, Sato M, et al. Early diagnosis of small pancreatic cancer: role of endoscopic ultrasonography. Dig Endosc 2009;21(Suppl 1):S92-96.
27. Tanaka K, Kida M. Role of endoscopy in screening of early pancreatic cancer and bile duct cancer. Dig Endosc 2009;21 (Suppl 1):S97-100.
28. Fedoravicius A, Adler DG. The role of endoscopic ultrasonography in patients with pancreatic cancer. Community Oncology 2008;5:382-386.
29. Tierney WM, Francis IR, Eckhauser F, et al. The accuracy of EUS and helical CT in the assessment of vascular invasion by peripapillary malignancy. Gastrointest Endosc 2001;53:182-188. (Pubitemid 32147599)
30. Palazzo L, Girollet PP, Salmeron M, et al. Value of endoscopic ultrasonography in the diagnosis of common bile duct stones: comparison with surgical exploration and ERCP. Gastrointest Endosc 1995;42:225-231.
31. Deprez P. Approach of suspected common bile duct stones: endoscopic ultrasonography. Acta Gastroenterol Belg 2000;63:295-298.
32. Sreenarasimhaiah J. Interventional endoscopic ultrasound: the next frontier in gastrointestinal endoscopy. Am J Med Sci 2009;338:319-324.
33. Zhang S, DeFrias DVS, Alasadi R, et al. Endoscopic ultrasound-guided fine needle aspiration (EUS-FNA): experience of an academic centre in the USA. Cytopathology 2010;21:35-43.
34. Kaufman M, Singh G, Das S, et al. Efficacy of endoscopic ultrasound-guided celiac plexus block and celiac plexus neurolysis for managing abdominal pain associated with chronic pancreatitis and pancreatic cancer. J Clin Gastroenterol 2010;44:127-134.
35. Hanada K, Iiboshi T, Ishii Y. Endoscopic ultrasound-guided choledochoduodenostomy for palliative biliary drainage in cases with inoperable pancreas head carcinoma. Dig Endosc 2009;21 (Suppl 1):S75-78.
36. Mallery S, Matlock J, Freeman ML. EUS-guided rendezvous drainage of obstructed biliary and pancreatic ducts: report of 6 cases. Gastrointest Endosc 2004;59:100-107. (Pubitemid 38095521)
37. Baron TH, Mallery JS, Hirota WK, et al. The role of endoscopy in the evaluation and treatment of patients with pancreaticobiliary malignancy. Gastrointest Endosc 2003;58:643-649.
38. Moss AC, Morris E, Leyden J, et al. Do the benefits of metal stents justify the costs? A systematic review and meta-analysis of trials comparing endoscopic stents for malignant biliary obstruction. Eur J Gastroenterol Hepatol 2007;19:1119-1124. (Pubitemid 350125385)
39. van Berkel AM, van MJ, Groen AK, et al. Mechanisms of biliary stent clogging: confocal laser scanning and scanning electron microscopy. Endoscopy 2005;37:729-734. (Pubitemid 41078905)
40. Chaurasia OP, Rauws EA, Fockens P, et al. Endoscopic techniques for retrieval of proximally migrated biliary stents: the Amsterdam experience. Gastrointest Endosc 1999;50:780-785.
41. Moss AC, Morris E, Leyden J, MacMathuna P. Malignant distal biliary obstruction: a systematic review and meta-analysis of endoscopic and surgical bypass results. Cancer Treat Rev 2007;33:213-221. (Pubitemid 46343103)
42. Tsuyuguchi T, Takada T, Miyazaki M, et al. Stenting and interventional radiology for obstructive jaundice in patients with unresectable biliary tract carcinomas. J Hepatobiliary Pancreat Surg 2008;15:69-73.
43. Ornellas LC, Stefanidis G, Chuttani R, et al. Covered Wallstents for palliation of malignant biliary obstruction: primary stent placement versus reintervention. Gastrointest Endosc 2009;70:676-683.
44. Kozarek RA. Metallic biliary stents for malignant obstructive jaundice: a review. World J Gastroenterol 2000;6:643-646.
45. Isayama H, Komatsu Y, Tsujino T, et al. A prospective randomised study of "covered" versus "uncovered" diamond stents for the management of distal malignant biliary obstruction. Gut 2004;53:729-734.
46. Shah RJ, Howell DA, Desilets DJ, et al. Multicenter randomized trial of the spiral Z-stent compared with the Wallstent for malignant biliary obstruction. Gastrointest Endosc 2003;57:830-836.
47. Howell DA, Sanders MK, Bernadino KP, et al. Randomised controlled trial (RCT) of a new nitinol non-forshortening self-expanding metal stent (SEMS) for malignant biliary obstruction: an international multi-center comparison in two diameters to Wallstent [abstract]. Gastrointest Endosc 2006;130(Suppl 2):Abstract 298.
48. Lacaine F, Fourtanier G, Fingerut A, et al. Surgical mortality and morbidity in malignant obstructive jaundice: a review of 373 patients. Eur J Surg 1995;161:729-734.
49. Armstrong CP, Dixon JM, Taylor V, et al. Surgical experience of deeply jaundiced patients with bile duct obstruction. Br J Surg 1984;71:234-238.
50. Baron TH, Kozarek RA. Preoperative biliary stents in pancreatic cancer - proceed with caution. N Engl J Med 2010;362:170-172.
51. Garcea G, Chee W, Ong SL, et al. Preoperative biliary drainage for distal obstruction the case against revisited. Pancreas 2010;39:119-126.
52. Coates JM, Beal SH, Russo JE1 et al. Negligible effect of selective preoperative biliary drainage on perioperative resuscitation, morbidity, and mortality in patients undergoing pancreaticoduodenectomy. Arch Surg 2009;144:841-847.
53. Hodul P, Creech S, Pickleman J, Aranha GV The effect of preoperative biliary stenting on postoperative complications after pancreaticoduodenectomy. Am J Surg 2003;186:420-425.
54. Pisters PW, Hudec WA, Hess KR, et al. Effect of preoperative biliary decompression on pancreaticoduodenectomy-associated morbidity in 300 consecutive patients. Ann Surg 2001;234:47-55.
55. van der Gaag NA, Rauws EA, van Ejick CH, et al. Preoperative biliary drainage for cancer of the head of the pancreas. N Engl J Med 2010;362:129-137.
56. Brugge WR. Advances in the endoscopic management of patients with pancreatic and biliary malignancies. South Med J 2006;99:1358-1366.
57. Neal CP, Thomasset SC, Bools D, et al. Combined percutaneous-endoscopic stenting of malignant biliary obstruction: results from 106 consecutive procedures and identification of factors associated with adverse outcome. Surg Endosc 2010;24:423-431.
58. Paik WH, Park YS, Hwang JH, et al. Palliative treatment with self- expandable metallic stents in patients with advanced type III or IV hilar cholangiocarcinoma: a percutaneous versus endoscopic approach. Gastrointest Endosc 2009;69:55-62.
59. Sol YL, Kim CW, Jeon UB, et al. Early infectious complications of percutaneous metallic stent insertion for malignant biliary obstruction. AJR Am J Roentgenol 2010;194:261-265.
60. Cress RD, Yin D, Clarke L, et al. Survival among patients with adenocarcinoma of the pancreas: a population-based study (United States). Cancer Causes Control 2006;17:403-409.
61. Strasberg SM, Drebin JA, Soper NJ. Evolution and current status of the Whipple procedure: an update for gastroenterologists. Gastroenterology 1997;113:983.
62. Diener M, Heukaeufer C, Schwarzer G, et al. Pancreaticoduodenectomy (classic Whipple) versus pylorus-preserving pancreaticoduodenectomy (pp Whipple) for surgical treatment of periampullary and pancreatic carcinoma. Cochrane Database Syst Rev 2008;CD006053.
63. Brennan MF, Moccia RD, Klimstra D. Management of adenocarcinoma of the body and tail of the pancreas. Ann Surg 1996;223:506-511.
64. Cameron JL, Riall TS, Coleman J, et al. One thousand consecutive pancreaticoduodenectomies. Ann Surg 2006;244:10-15.
65. Lim JE, Chien MW, Earle CC. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg 2003;237:74-85.
66. Schmidt CM., Powell ES, Yiannoutsos CT, et al. Pancreaticoduodenectomy: a 20-year experience in 516 patients. Arch Surg 2004;139:718-727.
67. Farley DR, Weaver AL, Nagomey DM. "Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention. Mayo Clin Proc 1995;70:425-429.
68. Yang J, Yan L. Current status of intrahepatic cholangiocarcinoma. World J Gastroenterol 2008;14:6289-6297.
69. Petrowsky H, Hong JC. Current surgical management of hilar and intrahepatic cholangiocarcinoma: the role of resection and orthotopic liver transplantation. Transplant Proc 2009;41:4023-4035.
70. Yamamoto M, Takasaki K, Otsubo T, et al. Recurrence after surgical resection of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 2001;8:154-157.
71. Casavilla FA, Marsh JW, Iwatsuki S, et al. Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg 1997;185:429-436.
72. Ghali P, Marotta PJ, Yoshida EM, et al. Liver transplantation for incidental cholangiocarcinoma: analysis of the Canadian experience. LiverTranspl 2005;11:1412-1416.
73. Stieber AC, Marino IR, Iwatsuki S, et al. Cholangiocarcinoma in sclerosing cholangitis. The role of liver transplantation. Int Surg 1989;74:1-3.
74. Gotto M, Bragazzi MC, Semeraro R, et al. Cholangiocarcinoma: update and future perspectives. Dig Liver Dis 2010;42:253-260.
75. Nakeeb A, Pitt HA, Sohn TA, et al. Cholangiocarcinoma: a spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996;224:463-473.
76. Jang JY, Kim SW, Park DJ, et al. Actual long-term outcome of Extrahepatic bile duct cancer after surgical resection. Ann Surg 2005;241:77-84.
77. Bortolasi L, Burgart LJ, Tsiotos GG, et al. Adenocarcinoma of the distal bile duct. A clinicopathologic outcome analysis after curative resection. Dig Surg 2000;17:36-41.
78. Neoptolemos JP, Talbot IC, Carr-Locke DL, et al. Treatment and outcome in 52 consecutive cases of ampullary carcinoma. Br J Surg 1987;74:957-961.
79. Bettschart V, Rahman MQ, Engelken FJF, et al. Presentation, treatment and outcome in patients with ampullary tumours. Br J Surg 2004;91:1600-1607. (Pubitemid 39619924)
80. Andersen JR, Sorensen SM, Kruse A, et al. Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice. Gut 1989;30:1132-1135. (Pubitemid 19202215)
81. Shepherd HA, Royle G, Ross AP, et al. Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: a randomized trial. Br J Surg 1988;75:1166-1168. (Pubitemid 19002642)
82. Kuhlmann KF, van Poll D, de Castro SM, et al. Initial and long-term outcome after palliative surgical drainage of 269 patients with malignant biliary obstruction. Eur J Surg Oncol 2007;33:757-762. (Pubitemid 47029665)
83. Gouma DJ, Busch OR, van Gulik TM. Pancreatic carcinoma: palliative surgical and endoscopic treatment. HPB (Oxford) 2006;8:369-376.
84. Sarfeh IJ, Rypins EB, Jakowatz JG, Juler GL. A prospective, randomized clinical investigation of cholecystoenterostomy and choledochoenterostomy. Am J Surg 1988;155:411-414. (Pubitemid 18086972)
85. Lillemoe KD, Cameron JL, Hardacre JM, et al. Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg 1999;230:322-328.
86. Adler DG, Baron TH. Endoscopic palliation of malignant gastric outlet obstruction using self-expanding metal stents: experience in 36 patients. Am J Gastroenterol 2002;97:72-78.
87. Jeumink SM, van Eijck CH, Steyerberg EW, et al. Stent versus gastrojejunostomy for the palliation of gastric outlet obstruction: a systematic review. BMC Gastroenterol 2007;7:18.